Description

Sorafenib is an oral medication used to treat advanced renal cell carcinoma and hepatocellular carcinoma. As a multi-kinase inhibitor, it targets tumor growth and blood vessel formation, effectively slowing cancer progression and improving overall survival rates for patients undergoing treatment.